What: At a maternal‐fetal medicine conference, researchers reported that one blood pressure drug yielded significantly better outcomes than its competitor, suggesting a potential reduction in maternal mortality.
Key line: [Details not provided].
Source: Medscape.
The 19th reports on the legal battles facing Dr. Margaret Carpenter over providing abortion pills, with questions about extradition and state protections.
A study found the Oura ring can pinpoint menstrual cycles with 96.4% accuracy.
One blood pressure medication outperformed another, potentially lowering postpartum readmission rates.
Research shows the causes of maternal mortality differ widely from state to state.
A state representative in Oregon took the witness stand to describe her personal experience with inadequate menopause care.
RFK Jr. demonstrated uncertainty over Medicare fundamentals during his nomination hearing.
Chiquita Brooks-LaSure warns that cuts by Elon Musk’s DOGE team could jeopardize health insurance coverage for many American women, affecting both Medicaid and Medicare.
A randomized control trial found that postpartum women treated with nifedipine had a dramatically lower readmission rate than those on labetalol.
Amid administrative chaos, the NIH acting director assured that key research projects would proceed.
A comprehensive Danish study reveals that while the absolute risk is low, hormonal contraceptives slightly increase the risk of ischemic stroke and sometimes heart attack.
Cannabis producers are exploring new treatment areas in women’s health.
Michigan law now allows pharmacists to prescribe birth control amid a shortage of OB/GYNs.
Emerging discussions about what happens after stopping hormonal birth control spark debate.
Vox examines strategies that might let Trump maintain a moderate image on abortion while enforcing restrictions.
A study reveals that from 2001 to 2020, early-onset breast cancer rates among women ages 25–39 varied significantly by region in the United States.
A study comparing sisters of women with and without pregnancy complications found that genetic and environmental factors may drive cardiovascular disease risk.
A study underscores that preventing preeclampsia is key to reducing serious postpartum complications.
An intimate essay describes the overwhelming stress of a high-risk pregnancy designation.
New York introduces a shield law to protect doctors who prescribe abortion medications.
Beyond recreation, cannabis is being evaluated for therapeutic benefits in women’s care.